← Browse by Condition
Medical Condition

asd

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for asd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — asd Clinical Trials

How many clinical trials are currently recruiting for asd?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for asd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for asd?
asd research spans Phase 1 (2 trials), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a asd clinical trial?
Eligibility criteria for asd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
1
Top Sponsors
Centre Hospitalier Universitaire, Amiens 1 trial
Adia Med of Winter Park LLC 1 trial
Greater Atlanta Integrative Pediatrics 1 trial
China Medical University Hospital 1 trial
Chen Li 1 trial

Recruiting Clinical Trials

NCT05194254
Recruiting
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
Enrollment
68 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07304440 Phase 1, Phase 2
Recruiting
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
Enrollment
100 pts
Location
United States
Sponsor
Adia Med of Winter Park LLC
View Trial →
NCT07622316 Phase 1
Recruiting
GAIP ASD Research Study
Enrollment
100 pts
Location
United States
Sponsor
Greater Atlanta Integrative Pe...
View Trial →
NCT07365553
Recruiting
Omega-3, Autism Spectrum Disorder (ASD)
Enrollment
50 pts
Location
Taiwan
Sponsor
China Medical University Hospi...
View Trial →
NCT07400484
Recruiting
Differences in N-CAD Concentration and Brain Function Between Children With ASD and TD
Enrollment
98 pts
Location
China
Sponsor
Chen Li
View Trial →

Related Conditions

autism spectrum disorder (2) autism (2) autism spectrum disorder asd (2) functional magnetic resonance imaging (1) eye tracking (1) social cognition (1) joint attention (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology